<DOC>
	<DOC>NCT02419677</DOC>
	<brief_summary>The purpose of this study is to determine whether combining of radiofrequency ablation (RFA) and cytokine-induced killer cells (CIK) transfusion can prolong survival of patients with colorectal cancer liver metastases (CRCLM).</brief_summary>
	<brief_title>Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases</brief_title>
	<detailed_description>The primary objective is to evaluate whether RFA followed by CIK transfusion can prolong survival of patients with resectable CRCLM.</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Patients with histologically confirmed adenocarcinoma Primary lesions (colorectal cancer) are resected Must have undergone prior complete resection of the primary tumor; liver metastases Must be resectable or accessible for radiofrequency ablation (Five or less lung metastases measuring 5 cm or smaller). Serum bilirubin level of 2.0 mg/dl or less. Performance status of 0 or 1. Expected survival of 1 year or more. Informed consent from the patient. With extrahepatic metastases With other neoplastic disease that is measurable or being treated other than colorectal cancer.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>radiofrequency ablation</keyword>
	<keyword>cytokine-induced killer cells</keyword>
	<keyword>colorectal cancer iver metastases</keyword>
</DOC>